Dr. Riley’s postdoctoral work done at the University of Pennsylvania has been published in Science Advances! In this work, we engineered lipid nanoparticles for in utero mRNA delivery, which can ultimately may be used for drug delivery to fetuses with congenital diseases prior to birth.